Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | TAS2R14 | Q9NYV8 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 2/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.38 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.38 |
| ▸ | FABP4 | P15090 | 1/20 | 0.38 |
| ▸ | CTNNB1 | P35222 | 2/20 | 0.37 |
| ▸ | WNT3A | P56704 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | KAT6A | Q92794 | 2/20 | 0.36 |
| ▸ | CTSS | P25774 | 1/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23041398 | 0.82 | LMNA (0.48) | LMNAGAATAS2R14ALDH1A1CNR2 | |
| SCHEMBL7399514 | 0.81 | LMNA (0.47) | LMNAGAATAS2R14ALDH1A1CNR2 | |
| SCHEMBL1195140 | 0.81 | TAS2R14 (0.51) | LMNAGAATAS2R14KDM4EALDH1A1 | |
| SCHEMBL2001643 | 0.79 | LMNA (0.46) | LMNAGAATAS2R14PTGS1KCNK3 | |
| SCHEMBL3108190 | 0.79 | LMNA (0.46) | LMNAGAATAS2R14CNR2PTGS1 | |
| SCHEMBL30554614 | 0.79 | PARP1 (0.47) | LMNAGAATAS2R14KDM4EALDH1A1 | |
| SCHEMBL28484672 | 0.79 | TAS2R14 (0.50) | LMNAGAATAS2R14KDM4EALDH1A1 | |
| SCHEMBL2189933 | 0.79 | LMNA (0.46) | LMNAGAATAS2R14ALDH1A1CNR2 | |
| SCHEMBL634076 | 0.79 | PARP1 (0.47) | LMNAGAATAS2R14KDM4EALDH1A1 | |
| SCHEMBL25404889 | 0.79 | LMNA (0.58) | LMNAGAAKDM4EALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11731988-B2 | Method for producing an organic electronic component, and organic electronic component | NOVALED GMBH (DE) | 2023-08-22 | — | — | US | disclosed |
| US-20210198285-A1 | Method for Producing an Organic Electronic Component, and Organic Electronic Component | NOVALED GMBH (DE) | 2021-07-01 | — | — | US | disclosed |
| US-11040988-B2 | Method for producing an organic electronic component, and organic electronic component | NOVALED GMBH (DE) | 2021-06-22 | — | — | US | disclosed |
| US-20170327516-A1 | Method for Producing an Organic Electronic Component, and Organic Electronic Component | OSRAM OLED GMBH (DE) | 2017-11-16 | — | — | US | disclosed |
| US-20170317288-A1 | Method for Producing an Organic Electronic Component, and Organic Electronic Component | NOVALED GMBH (DE) | 2017-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170327516-A1 | Method for Producing an Organic Electronic Component, and Organic Electronic Component | OR10J3, AP2M1, OPRM1 | LMNA 1909/4885GAA 4284/4885TAS2R14 2191/4885 |
| US-11040988-B2 | Method for producing an organic electronic component, and organic electronic component | EPCAM, OSTC, L1CAM | LMNA 1475/4885GAA 3190/4885TAS2R14 3016/4885 |
| US-11731988-B2 | Method for producing an organic electronic component, and organic electronic component | AP2M1, OR10J3, OPRM1 | LMNA 1767/4885GAA 4266/4885TAS2R14 2318/4885 |
| US-20210198285-A1 | Method for Producing an Organic Electronic Component, and Organic Electronic Component | AP2M1, OR10J3, OPRM1 | LMNA 1767/4885GAA 4266/4885TAS2R14 2318/4885 |
| US-20170317288-A1 | Method for Producing an Organic Electronic Component, and Organic Electronic Component | EPCAM, OSTC, L1CAM | LMNA 1475/4885GAA 3190/4885TAS2R14 3016/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.